Liposomal Bupivacaine (Exparel) in Sarcomas
Stopped Enrollment of eligible subjects, delays due to the COVID-19 Virus, and lack of funding
Conditions
- Soft Tissue Sarcoma
- Soft Tissue Tumor
- Soft Tissue Tumor and/or Sarcoma
Interventions
- DRUG: Liposomal Bupivacaine
Sponsor
Wake Forest University Health Sciences